Envision Sciences announces thee appointment of new chief executive officer

Clinical diagnostics company Envision Sciences has appointed Scott Richards as its new chief executive officer. Envision is developing and commercialising a pipeline of novel biomarker-based cancer diagnostic and prognostic tests in tissue and blood. Mr Richards has over 35 years of experience in the global pharmaceutical industry, leading significant commercial-stage enterprises in Australia, Europe and […]

Quest Diagnostics Launches Novel Prostate Cancer Test Aimed at Improving Diagnosis and Grading

Lab service utilizes Envision Science’s proprietary biomarkers and technology with a goal of improving diagnosis and grading of prostate cancer SECAUCUS, N.J. and MELBOURNE, Australia, July 13, 2023 /PRNewswire/ — Quest Diagnostics (NYSE: DGX), the leading provider of diagnostic information services, today announced the launch of a novel prostate cancer biomarker test through its subspecialty pathology […]